Descriptive epidemiology of neuromyelitis optica in the Caribbean basin;Épidémiologie descriptive de la neuromyélite optique dans le bassin caraïbéen

Revue Neurologique

Volumn 165, Issue 8-9, 2009, Pages 676-683

  Cabre, P ^a   Gonzalez Quevedo, A ^b   Lannuzel, A ^c   Bonnan, M ^a   Merle, H ^d   Olindo, S ^a   Chausson, N ^a   Lara Rodriguez, R ^e   Smadja, D ^a   Cabrera Gomez, J ^f  

^a Service de Neurologie   (Martinique)

^b INSTITUTO DE NEUROLOGÍA Y NEUROCIRUGÍA   (Cuba)

^c CHRU   (Guadeloupe)

^d CHRU   (Martinique)

^e HOSPITAL UNIVERSITARIO GENERAL CALIXTO GARCÍA   (Cuba)

^f CENTRO INTERNACIONAL DE RESTAURACIÓN NEUROLÓGICA CIREN   (Cuba)

Author keywords

Caribbean Basin; Diagnostic criteria; Incidence; Neuromyelitis optica; Prevalence

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; ASIAN; CARIBBEAN ISLANDS; CENTRAL AMERICA; CUBA; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYELOOPTIC NEUROPATHY; POPULATION RISK; PREVALENCE; RACE DIFFERENCE; SEX DIFFERENCE; ADOLESCENT; AGE; ETHNIC GROUP; KAPLAN MEIER METHOD; MARTINIQUE; MIDDLE AGED; NOMENCLATURE;

ADOLESCENT; ADULT; AGE FACTORS; CARIBBEAN REGION; CUBA; ETHNIC GROUPS; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MARTINIQUE; MIDDLE AGED; NEUROMYELITIS OPTICA; SEX FACTORS; TERMINOLOGY AS TOPIC; YOUNG ADULT;

EID: 70049116099     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurol.2009.02.012     Document Type: Article

References (33)

1. Barbieri F., and Buscaino G.A. Neuromyelitis optica in the elderly. Acta Neurol 11 (1989) 247-251
2. Cabre P., Heinzlef O., Merle H., et al. MS and neuromyelitis optica in Martinique (French West Indies). Neurology 56 (2001) 507-514
3. Cabre P., Signate A., Olindo S., et al. Role of return migration in the emergence of multiple sclerosis in the French West Indies. Brain 128 (2005) 2899-2910
4. Cabrera-Gomez J.A., Kurtzke J.F., Gonzalez-Quevedo A., and Lara-Rodriguez R. An epidemiological study of neuromyelitis optica in Cuba. J Neurol 256 (2009) 35-44
5. Ch'ien L.R., Medeiros M.O., Belluomini J.J., Lemmi H., and Whitaker J.N. Neuromyelitis optica (Devic's syndrome) in two sisters. Clin Electroencephalogr 13 (1982) 36-39
6. Chopra J.S., Radakhrishnan K., Sawhney B.B., Pal S.R., and Banerjee A.K. Multiple sclerosis in North-West-India. Acta Neurol Scand 62 (1980) 312-321
7. Cosnett J.E. Multiple sclerosis and neuromyelitis optica. Case report and speculation. S Afr Med J 60 (1981) 249-251
8. Cree B.A., Khan O., Bourdette D., et al. Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis. Neurology 63 (2004) 2039-2045
9. Das A., and Puvanendran K. A retrospective review of patients with clinically definite multiple sclerosis. Ann Acad Med Singapore 27 (1998) 204-209
10. De Seze J., Lebrun C., Stojkovic T., Ferriby D., Chatel M., and Vermersch P. Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis. Mult Scler 9 (2003) 521-525
11. Fukazawa T., Yamasaki K., Ito H., et al. Both the HLA-CPB1 and DRB1 alleles correlate with risk for multiple sclerosis in Japanese clinical phenotypes and gender as important factors. Tissue Antigens 55 (2000) 199-205
12. Gangopadhyay G., Das S.K., Sarda P., et al. Clinical profile of multiple sclerosis in Bengal. Neurol India 47 (1999) 18-21
13. Ghezzi A., Bergamaschi R., Martinelli V., et al. Clinical characteristics, course and prognosis of relapsing Devic's neuromyelitis optica. J Neurol 251 (2004) 47-52
14. Hibberd P.L. Use and misuse of statistics for epidemiological studies of multiple sclerosis. Ann Neurol 36 suppl. 2 (1994) S218-S230
15. Kira J., Yamasaki K., Horiuchi I., Ohyagi Y., Taniwaki T., and Kawano Y. Changes in the clinical phenotypes of multiple sclerosis during the past 50 years in Japan. J Neurol Sci 166 (1999) 53-57
16. Kira J. Multiple sclerosis in the Japanese population. Lancet Neurol 2 (2003) 17-27
17. Lau K.K., Wong L.K., Li L.S., Chan Y.W., Li H.L., and Wong V. Epidemiological study of multiple sclerosis in Hong-Kong Chinese: questionnaire survey. Hong Kong Med J 8 (2002) 77-80
18. Lennon V., Wingerchuk D.M., Kryzer T., et al. A serum autoantibody marker of NMO: distinction from multiple sclerosis. Lancet 364 (2004) 2106-2112
19. Mc Alpine D. Familial neuromyelitis optica: its occurrence in identical twins. Brain 61 (1938) 430-448
20. McKeon A., Lennon V.A., Lotze S., et al. CNS aquaporin-4 autoimmunity in children. Neurology 71 (2008) 93-100
21. Mirsattari S.M., Johnston J.B., McKenna R., et al. Aboriginals with multiple sclerosis: HLA types and predominance of neuromyelitis optica. Neurology 56 (2001) 317-323
22. Modi G., Mochan A., Modi M., and Saffer D. Demyelinating disorder of the central nervous system occurring in Black South Africans. J Neurol Neurosurg Psychiatry 70 (2001) 500-505
23. Nakashima I., Fujihara K., Takase S., and Itoyama Y. Decrease in multiple sclerosis with acute transverse myelitis in Japan. Tohoku J Exp Med 188 (1999) 89-94
24. O'Riordan J.I., Gallagher H.L., Thompson A.J., et al. Clinical, CSF, and MRI's findings in neuromyelitis optica (Devic's disease). J Neurol Neurosurg Psychiatry 60 (1996) 382-387
25. Osuntokun B.O. The pattern of neurological illness in tropical Africa. Experience at Ibadan, Nigeria. J Neurol Sci 12 (1971) 417-442
26. Papais Alvarenga R.M., Mirando-Santos, Puccioni-Sohler M., et al. Optic neuromyelitis syndrome in Brazilian patients. J Neurol Neurosurg Psychiatry 73 (2002) 429-435
27. Philipps P.H., Newman N.J., and Lynn M.J. Optic neuritis in African Americans. Arch Neurol 55 (1998) 186-192
28. Vernant J.C., Cabre P., Smadja D., et al. Recurrent optic neuromyelitis with endocrinopathies: a new syndrome. Neurology 48 (1997) 58-64
29. Yamasaki K., Horiuchi I., Minohara M., et al. HLA-DPB1-0501-associated multiple sclerosis: clinical, neuroimaging, and immunogenetic studies. Brain 122 (1999) 1689-1696
30. Yamakawa K., Kuroda H., Fujihara K., et al. Familial neuromyelitis optica (Devic's syndrome) with late onset in Japan. Neurology 55 (2000) 318-319
31. Wingerchuk D.M., Lennon V.A., Pittock S.J., Lucchinetti C.F., and Weinshenker B.G. The clinical course of neuromyelitis optica (Devis syndrome). Neurology 53 (1999) 1107-1114
32. Wingerchuk D.M., Lennon V.A., Pittock S.J., Lucchinetti C.F., and Weinshenker B.G. Revised diagnostic criteria in NMO. Neurology 66 (2006) 1485-1489
33. Wingerchuk D.M., Lennon V.A., Lucchinetti C.F., Pittock S.J., and Weinshenker B.G. The spectrum of NMO. Lancet Neurol 6 (2007) 805-815